Sign up to save your podcasts
Or
Share Optimizing Mechanistic Models for Drug Development | Andrew Matteson, Ph.D.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Optimizing Mechanistic Models for Drug Development | Andrew Matteson, Ph.D.
Here, we speak with Andrew Matteson, Ph.D. Andrew graduated with his PhD in computational biology in 2013 from New York University. He is now a principal scientist at Applied BioMath working to develop mechanistic models through mathematical optimization for drug development.
We discuss mathematical optimization and drug development, software development in industry, balancing industry interests for graduate students, and much more.
Don't forget to follow the Goldwater Scholar Community on Facebook, Instagram, LinkedIn, and Twitter!
View all episodes
By Goldwater Scholar Highlights
5
44 ratings
Here, we speak with Andrew Matteson, Ph.D. Andrew graduated with his PhD in computational biology in 2013 from New York University. He is now a principal scientist at Applied BioMath working to develop mechanistic models through mathematical optimization for drug development.
We discuss mathematical optimization and drug development, software development in industry, balancing industry interests for graduate students, and much more.
Don't forget to follow the Goldwater Scholar Community on Facebook, Instagram, LinkedIn, and Twitter!